Vivo Capital is a global healthcare investment firm founded in 1996, specializing in investments across venture capital, private equity, and public equity strategies. With approximately $5.8 billion in assets under management, the firm has invested in over 290 public and private companies worldwide. Headquartered in Palo Alto, California, Vivo Capital also maintains offices in Beijing, Shanghai, Hong Kong, and Taipei.

The firm's investment focus spans biopharmaceuticals, specialty pharmaceuticals, medical devices, and healthcare services, primarily targeting the U.S. and East Asia markets, particularly China. Vivo Capital employs a multi-pronged strategy, identifying and collaborating with companies developing and commercializing innovative healthcare products and technologies.

The firm's team comprises professionals with backgrounds in medicine, science, and entrepreneurship, enabling effective navigation of the healthcare sector's complexities.